Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ectopic expression of HIV-1 Tat modifies gene expression in cultured B cells: implications for the development of B-cell lymphomas in HIV-1-infected patients. | PeerJ | 2022 | 36275462 | PubTator, text mining | PubMed |
| Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis. | J Oncol | 2022 | 36268282 | PubTator, text mining | PubMed |
| Reprogramming of sentinel lymph node microenvironment during tumor metastasis. | J Biomed Sci | 2022 | 36266717 | PubTator, text mining | PubMed |
| Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer. | BMC Bioinformatics | 2022 | 36261786 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. | Adv Sci (Weinh) | 2022 | 36253096 | PubTator, text mining | PubMed |
| Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment. | Front Immunol | 2022 | 36248808 | PubTator, text mining | PubMed |
| Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36248785 | PubTator, text mining | PubMed |
| HSPA1A, HSPA2, and HSPA8 Are Potential Molecular Biomarkers for Prognosis among HSP70 Family in Alzheimer's Disease. | Dis Markers | 2022 | 36246562 | PubTator, text mining | PubMed |
| Inhibition of CCR8 attenuates Ang Ⅱ-induced vascular smooth muscle cell injury by suppressing the MAPK/NF-κB pathway. | Iran J Basic Med Sci | 2022 | 36246058 | PubTator, text mining | PubMed |
| Increased Expression of NXPH4 Correlates with Immune Cell Infiltration and Unfavorable Prognosis in Hepatocellular Carcinoma. | J Oncol | 2022 | 36245978 | PubTator, text mining | PubMed |
| Therapeutic strategies for gastric cancer targeting immune cells: Future directions. | Front Immunol | 2022 | 36225938 | PubTator, text mining | PubMed |
| Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis. | Front Cardiovasc Med | 2022 | 36211578 | PubTator, text mining | PubMed |
| Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma. | Front Cell Infect Microbiol | 2022 | 36204642 | PubTator, text mining | PubMed |
| Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4+Foxp3+ regulatory T cells. | Phytomedicine | 2022 | 36202057 | PubTator, text mining | PubMed |
| Yeast U6 snRNA made by RNA polymerase II is less stable but functional. | RNA | 2022 | 36195346 | PubTator, text mining | PubMed |
Reconsideration of the Role of Regulatory T Cells during Pregnancy: Differential Characteristics of Regulatory T Cells between the Maternal-Fetal Interface and Peripheral Sites and between Early and Late Pregnancy. | Med Princ Pract | 2022 | 36195068 | PubTator, text mining | PubMed |
| High APLN Expression Predicts Poor Prognosis for Glioma Patients. | Oxid Med Cell Longev | 2022 | 36193059 | PubTator, text mining | PubMed |
| The expanding impact of T-regs in the skin. | Front Immunol | 2022 | 36189219 | PubTator, text mining | PubMed |
| Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers. | World J Gastrointest Oncol | 2022 | 36187394 | PubTator, text mining | PubMed |
| The DPY30-H3K4me3 Axis-Mediated PD-L1 Expression in Melanoma. | J Inflamm Res | 2022 | 36185638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=26